FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3003050961> ?p ?o ?g. }

• W3003050961 endingPage "408.e1" @default.
• W3003050961 startingPage "401" @default.
• W3003050961 abstract "To evaluate the toxicity and survival of hepatocellular carcinoma (HCC) secondary to hepatitis B virus (HBV) infection treated with yttrium-90 transarterial radioembolization (TARE) over a 15-year period.This study retrospectively analyzed 93 consecutive patients with HBV HCC-all derived from an original cohort of 1,000 patients-who were treated with TARE via standard radiation segmentectomy/lobectomy between December 2003 and December 2018. This group comprised 80 males and 13 females, with 79 having only HBV and 14 having additional liver comorbidities. Toxicity grades were determined by Common Terminology Criteria for Adverse Events, version 5.0. Overall survival (OS) was reported using intention-to-treat (ITT), censored, or competing risk. Univariate/multivariate analyses were used to evaluate predictors of OS.Posttreatment grade 3/4 toxicities included albumin (1.1%), bilirubin (4.3%), aspartate transaminase (6.5%), and alanine transaminase (3.2%). Median censored OS was 16.9 months (95% confidence interval [CI], 11.8-23.5): 17.5 months (95% CI, 11.5-86.9) for Child-Pugh (CP) A and 14.5 months (95% CI, 5.2-22.5) for CP B; not reached, 16.9 months (95% CI, 11.2-68.7), and 11.5 months (95% CI, 8.6-17.5) for Barcelona Clinic Liver Cancer (BCLC) A, B, and C, respectively. Multivariate analysis revealed albumin, alpha-fetoprotein, and portal vein thrombosis as independent predictors of ITT OS and albumin and tumor size as predictors when curative therapy was assigned as a competing risk.This retrospective study showed that TARE therapy resulted in minimal toxicity in patients with HBV-derived HCC. Patients with CP A or BCLC A disease had superior survival outcomes compared to patients with CP B and BCLC B/C disease. These findings suggest that TARE is a viable treatment option for certain patient groups with HCC tumors secondary to HBV infection." @default.
• W3003050961 created "2020-01-30" @default.
• W3003050961 creator A5011003738 @default.
• W3003050961 creator A5033464248 @default.
• W3003050961 creator A5044862107 @default.
• W3003050961 creator A5072356141 @default.
• W3003050961 creator A5075153200 @default.
• W3003050961 creator A5085978876 @default.
• W3003050961 creator A5087536545 @default.
• W3003050961 date "2020-03-01" @default.
• W3003050961 modified "2023-10-13" @default.
• W3003050961 title "Toxicity and Survival of Hepatocellular Carcinoma Patients with Hepatitis B Infection Treated with Yttrium-90 Radioembolization: An Updated 15-Year Study" @default.
• W3003050961 cites W1964705435 @default.
• W3003050961 cites W1971837077 @default.
• W3003050961 cites W1982200516 @default.
• W3003050961 cites W1984869178 @default.
• W3003050961 cites W1994193851 @default.
• W3003050961 cites W1998417832 @default.
• W3003050961 cites W2000724394 @default.
• W3003050961 cites W2018881820 @default.
• W3003050961 cites W2026933907 @default.
• W3003050961 cites W2067109440 @default.
• W3003050961 cites W2071019693 @default.
• W3003050961 cites W2077014377 @default.
• W3003050961 cites W2080335237 @default.
• W3003050961 cites W2101348459 @default.
• W3003050961 cites W2128125049 @default.
• W3003050961 cites W2137052325 @default.
• W3003050961 cites W2138424758 @default.
• W3003050961 cites W2145822754 @default.
• W3003050961 cites W2147172608 @default.
• W3003050961 cites W2147188187 @default.
• W3003050961 cites W2509930573 @default.
• W3003050961 cites W2754961196 @default.
• W3003050961 cites W2765356289 @default.
• W3003050961 cites W2772445760 @default.
• W3003050961 cites W2786747248 @default.
• W3003050961 cites W2791703762 @default.
• W3003050961 cites W2794444859 @default.
• W3003050961 cites W2917837889 @default.
• W3003050961 cites W2997727194 @default.
• W3003050961 doi "https://doi.org/10.1016/j.jvir.2019.08.033" @default.
• W3003050961 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31983593" @default.
• W3003050961 hasPublicationYear "2020" @default.
• W3003050961 type Work @default.
• W3003050961 sameAs 3003050961 @default.
• W3003050961 citedByCount "7" @default.
• W3003050961 countsByYear W30030509612020 @default.
• W3003050961 countsByYear W30030509612021 @default.
• W3003050961 countsByYear W30030509612023 @default.
• W3003050961 crossrefType "journal-article" @default.
• W3003050961 hasAuthorship W3003050961A5011003738 @default.
• W3003050961 hasAuthorship W3003050961A5033464248 @default.
• W3003050961 hasAuthorship W3003050961A5044862107 @default.
• W3003050961 hasAuthorship W3003050961A5072356141 @default.
• W3003050961 hasAuthorship W3003050961A5075153200 @default.
• W3003050961 hasAuthorship W3003050961A5085978876 @default.
• W3003050961 hasAuthorship W3003050961A5087536545 @default.
• W3003050961 hasConcept C126322002 @default.
• W3003050961 hasConcept C141071460 @default.
• W3003050961 hasConcept C144301174 @default.
• W3003050961 hasConcept C160160445 @default.
• W3003050961 hasConcept C167135981 @default.
• W3003050961 hasConcept C181199279 @default.
• W3003050961 hasConcept C185592680 @default.
• W3003050961 hasConcept C197934379 @default.
• W3003050961 hasConcept C2776231280 @default.
• W3003050961 hasConcept C2777382497 @default.
• W3003050961 hasConcept C2777513400 @default.
• W3003050961 hasConcept C2777793932 @default.
• W3003050961 hasConcept C2778019345 @default.
• W3003050961 hasConcept C2778606649 @default.
• W3003050961 hasConcept C2779679107 @default.
• W3003050961 hasConcept C38180746 @default.
• W3003050961 hasConcept C55493867 @default.
• W3003050961 hasConcept C71924100 @default.
• W3003050961 hasConcept C90924648 @default.
• W3003050961 hasConceptScore W3003050961C126322002 @default.
• W3003050961 hasConceptScore W3003050961C141071460 @default.
• W3003050961 hasConceptScore W3003050961C144301174 @default.
• W3003050961 hasConceptScore W3003050961C160160445 @default.
• W3003050961 hasConceptScore W3003050961C167135981 @default.
• W3003050961 hasConceptScore W3003050961C181199279 @default.
• W3003050961 hasConceptScore W3003050961C185592680 @default.
• W3003050961 hasConceptScore W3003050961C197934379 @default.
• W3003050961 hasConceptScore W3003050961C2776231280 @default.
• W3003050961 hasConceptScore W3003050961C2777382497 @default.
• W3003050961 hasConceptScore W3003050961C2777513400 @default.
• W3003050961 hasConceptScore W3003050961C2777793932 @default.
• W3003050961 hasConceptScore W3003050961C2778019345 @default.
• W3003050961 hasConceptScore W3003050961C2778606649 @default.
• W3003050961 hasConceptScore W3003050961C2779679107 @default.
• W3003050961 hasConceptScore W3003050961C38180746 @default.
• W3003050961 hasConceptScore W3003050961C55493867 @default.
• W3003050961 hasConceptScore W3003050961C71924100 @default.
• W3003050961 hasConceptScore W3003050961C90924648 @default.
• W3003050961 hasIssue "3" @default.
• W3003050961 hasLocation W30030509611 @default.

• next